Oral Hypoglycemic Medications

Course Overview

Course Outline

• Introduction 
• Type 2 Diabetes Mellitus 
  • Risk factors. 
  • Pathophysiology 
• Oral Hypoglycemic Agents 
  • Sulfonylureas 
  • Meglitinides 
  • Biguanides 
  • Thiazolidinediones 
  • Alpha-Glucosidase Inhibitors 
  • DPP-4 Inhibitors 
  • SGLT2 Inhibitors 
  • Cycloset 
    • Indications  
    • Mechanisms of Action and Pharmacokinetics 
    • Contraindications and Precautions  
    • Adverse Effects and Black Box Warnings  
    • Drug Interactions 
• Guidelines on Corticosteroid Use  
• Patient Teaching  
• Future Implications  
• Conclusion

Accreditation Statement

Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

In this course, we will discuss Oral Hypoglycemic Medications. It will take the average learner 180 minutes to complete and awards 3 contact hours of continuing education.

Course Outcomes

After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:

1. Describe the risk factors and pathophysiology of Type 2 Diabetes Mellitus (DM).  
2. Analyze the pros and cons of each oral hypoglycemic agent class. 
3. Evaluate which oral hypoglycemic agents are considered first-line therapy. 
4. Create oral hypoglycemic treatment recommendations when first-line therapy is unsuccessful.

Target Audience

• Registered Nurses (RN)
• Advanced Practice Registered Nurses (APRN)
• Licensed Practical Nurses (LPN/LVN)

Requirement for Completion

1. Enrollment in the course by the learner
2. Read and learn all course materials
3. Complete the course evaluation
4. Attest and testify learning of the course materials

Accreditations + Approvals

Disclosure of Relevant Financial Relationships

Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.